Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biomarkers associated with response to Tysabri in multiple sclerosis
2008-005906-38Phase 4Active
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Mar 2009
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of natalizumab in multiple sclerosis (MS), sponsored by Centre hospitalier universitaire de Toulouse. Primary endpoint: Genetic biomarker objective. Started Mar 2009; status: active.
02
Drugs
natalizumab
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2008-005906-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005906-38.